Pfizer's Chairman and CEO Albert Bourla said the company is sending medicines worth USD 70 million (over Rs 510 crore) from its distribution centers in the US, Europe, and Asia that have been listed as part of India's COVID-19 treatment protocol.
Pfizer to send COVID-19 treatment drugs worth $70 mn to India
The firm will be sending drugs that have been identified as part of India s COVID-19 treatment protocol, according to Pfizer s Chairman and CEO Albert Bourla.
BusinessToday.In | May 3, 2021 | Updated 14:31 IST
Bourla shared a mail that had been sent to Pfizer s employees in India
American pharmaceutical giant Pfizer announced on Monday that it is sending medicines worth $70 million to India. The firm will be sending drugs that have been identified as part of India s COVID-19 treatment protocol, according to Pfizer s Chairman and CEO Albert Bourla. The medicines will come from Pfizer s distribution centres in the US, Europe and Asia.